Averto Medical

Averto Medical is a clinical-stage medtech startup developing a novel device aimed at protecting anastomoses (surgical connections) in colorectal and other gastrointestinal surgeries. The company is privately held and appears to be in the clinical evaluation stage of its first product. Led by CEO Kenton Fong and backed by a board including experienced investors and executives, Averto is targeting a significant unmet need in surgical care where anastomotic leaks lead to severe complications, increased costs, and patient mortality. Its success hinges on clinical validation, regulatory clearance, and subsequent commercial adoption in a competitive surgical device market.

Medical device platform focused on anastomosis protection for gastrointestinal surgery.

The competitive landscape includes major medical device companies (e.g., Baxter, BD, J&J) with broad surgical product portfolios, as well as specialized firms offering sealants, glues, and buttressing materials. Averto must differentiate through superior clinical data, ease of use, and a clear economic value proposition to capture market share from these incumbents.